Paradigm Medical Industries, Inc. (OTCBB: PMED), a leader in glaucoma diagnostic and management devices, disclosed today it has entered into a consulting agreement with Corcoran Consulting Group (San Bernardino, CA). Terms were not disclosed. Corcoran Consulting Group (CCG) specializes in medical reimbursement issues for optometry and ophthalmology. Kevin Corcoran, president of CCG, is recognized as a leading expert in the field of medical billing.
CCG will provide a variety of services for Paradigm Medical, including training, seminars, publications, and telephone and trade show support. “We will be working closely with CCG to create new category codes for our Blood Flow Analyzer™ (BFA), as well as offering educational seminars for physicians and practitioners,” said Paradigm Medical’s Chief Executive Officer, Raymond Cannefax. “We are pleased to be working with Kevin Corcoran and his team, and expect CCG to enhance Paradigm Medical’s product offerings and market presence.”
BFAs are used by doctors in their patient evaluation and management of glaucoma and pressure related to eye ailments. CCG may also provide services designed at creating greater industry acceptance and recognition of Paradigm Medical’s P60 Ultrasound BioMicroscope (UBM).
Paradigm Medical Industries, Inc., is a leader in Ultrasound devices, and glaucoma detection and management products.
This press release contains statements that, if not verifiable historic fact, may be viewed as forward-looking statements that could predict future events and outcomes with respect to Paradigm and its business. The predictions embodied in these statements will involve risk and uncertainties and, accordingly, actual results may differ significantly from the results discussed or implied in such forward-looking statements.
Paradigm Medical Industries, Inc.
Joy Roop, 801-977-8970
www.paradigm-medical.com